Literature DB >> 11872613

Global attentional-executive sequelae following surgical lesions to globus pallidus interna.

Richard B Scott1, John Harrison, Charlotte Boulton, Joanna Wilson, Ralph Gregory, Simon Parkin, Peter G Bain, Carol Joint, John Stein, Tipu Z Aziz.   

Abstract

It has been demonstrated that selective unilateral surgical ablation of posteroventral globus pallidus interna relieves the movement disorders associated with advanced Parkinson's disease, without necessarily incurring the executive cognitive sequelae that have been observed following gross pathological lesions to this brain region. This finding is consistent with established theory that underlying neuronal circuitry is functionally segregated into parallel cortico-striatal-pallidal-thalamo-cortical 'loops'. We have studied a series of 12 patients with advanced Parkinson's disease at baseline, and then following bilateral pallidotomy, with a battery of neuropsychological tests including the Cambridge Neuro psychological Test Automated Battery. We identified a selective and universal loss of individual patients' ability to shift attention to novel dimensions in a test of abstract rule-learning following surgery, which was not reliably associated with any other change in cognition, personality, mood or medication. This finding is rare in its specificity and has implications for theoretical models of the functional architecture and pathophysiology of the globus pallidus, and the clinical practice of pallidotomy.

Entities:  

Mesh:

Year:  2002        PMID: 11872613     DOI: 10.1093/brain/awf046

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  14 in total

1.  Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis.

Authors:  Toshikazu Ikuta; Delbert G Robinson; Juan A Gallego; Bart D Peters; Patricia Gruner; John Kane; Majnu John; Serge Sevy; Anil K Malhotra; Philip R Szeszko
Journal:  Psychiatry Res       Date:  2013-10-10       Impact factor: 3.222

2.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

3.  Intrinsic Connectivity of the Globus Pallidus: An Uncharted Marker of Functional Prognosis in People With First-Episode Schizophrenia.

Authors:  Goda Tarcijonas; William Foran; Gretchen L Haas; Beatriz Luna; Deepak K Sarpal
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 4.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

5.  Neurodegeneration across stages of cognitive decline in Parkinson disease.

Authors:  Daniel Weintraub; Jimit Doshi; Deepthi Koka; Christos Davatzikos; Andrew D Siderowf; John E Duda; David A Wolk; Paul J Moberg; Sharon X Xie; Christopher M Clark
Journal:  Arch Neurol       Date:  2011-12

Review 6.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

7.  Deep brain stimulation in childhood: an effective treatment for early onset idiopathic generalised dystonia.

Authors:  Jeremy R Parr; Alex L Green; Carole Joint; Morag Andrew; Ralph P Gregory; Richard B Scott; Michael A McShane; Tipu Z Aziz
Journal:  Arch Dis Child       Date:  2007-04-25       Impact factor: 3.791

8.  The subcortical basis of outcome and cognitive impairment in TBI: A longitudinal cohort study.

Authors:  Evan S Lutkenhoff; Matthew J Wright; Vikesh Shrestha; Courtney Real; David L McArthur; Manuel Buitrago-Blanco; Paul M Vespa; Martin M Monti
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910

9.  From multidimensional neuropsychological outcomes to a cognitive complication rate: the International Subarachnoid Aneurysm Trial.

Authors:  Richard B Scott; Fiona Eccles; Andrew Lloyd; Katherine Carpenter
Journal:  Trials       Date:  2008-03-14       Impact factor: 2.279

10.  Expression and new exon mutations of the human Beta defensins and their association on colon cancer development.

Authors:  Abdelhabib Semlali; Abdullah Al Amri; Arezki Azzi; Omair Al Shahrani; Maha Arafah; Muhammad Kohailan; Abdulrahman M Aljebreen; Othman Alharbi; Majid A Almadi; Nahla Ali Azzam; Narasimha Reddy Parine; Mahmoud Rouabhia; Mohammad S Alanazi
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.